|
The approved gene symbols and names in reference to HUGO Gene Nomenclature |
|
| Gene symbol |
Gene name |
|
|
|
| AKR1C1; AKR1C2 |
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase); aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) |
| TM4SF1 |
transmembrane 4 L six family member 1 |
| NR0B1 |
nuclear receptor subfamily 0, group B, member 1 |
| LRPPRC |
leucine-rich PPR-motif containing |
| SFRS3 |
splicing factor, arginine/serine-rich 3 |
| ABCG2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
| Unidentified 1 |
adult retina protein |
| KRT4 |
keratin 4 |
| ZNF567 |
zinc finger protein 567 |
| IL6R |
interleukin 6 receptor |
| PAMCI |
peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor |
| ZNF267 |
zinc finger protein 267 |
| NEFL |
neurofilament, light polypeptide 68 kDa |
| SFMBT2 |
Scm-like with four mbt domains 2 |
| FSTL1 |
follistatin-like 1 |
| TMEPAI |
transmembrane, prostate androgen induced RNA |
| COL5A1 |
collagen, type V, alpha 1 |
| SLC6A15 |
solute carrier family 6, member 15 |
| COL1A1 |
collagen, type I, alpha 1 |
| NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
| CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
| ANXA8 |
annexin A8 |
| THBD |
thrombomodulin |
| RAB3B |
RAB3B, member RAS oncogene family |
| ADAM19 |
ADAM metallopeptidase domain 19 (meltrin beta) |
| COL4A2 |
collagen, type IV, alpha 2 |
| IGFBP7 |
insulin-like growth factor binding protein 7 |
| COL4A1 |
collagen, type IV, alpha 1 |
| IFI16 |
interferon, gamma-inducible protein 16 |
| GLIPR1 |
GLI pathogenesis-related 1 (glioma) |
| TGM2 |
transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) |
| COL4A1 |
collagen, type IV, alpha 1 |
| IGFBP7 |
insulin-like growth factor binding protein 7 |
| MYL9 |
myosin, light chain 9, regulatory |
| Unidentified 2 |
CDNA FLJ44429 fis, clone UTERU2015653 |
| MATN2 |
matrilin 2 |
| TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
| FRMD5 |
FERM domain containing 5 |
| RUNX2 |
runt-related transcription factor 2 |
| TMEPAI |
transmembrane, prostate androgen induced RNA |
| GLIPR1 |
GLI pathogenesis-related 1 (glioma) |
| NPTX1 |
neuronal pentraxin I |
| GLIPR1 |
GLI pathogenesis-related 1 (glioma) |
| SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
| COL5A1 |
collagen, type V, alpha 1 |
| COL1A1 |
collagen, type I, alpha 1 |
| B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| Unidentified 3 |
- |
| TNS1 |
tensin 1 |
| SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
| MOBKL2B |
MOB1, Mps One Binder kinase activator-like 2B (yeast) |
| ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| C4orf18 |
chromosome 4 open reading frame 18 |
| COL5A1 |
collagen, type V, alpha 1 |
| TAGLN |
transgelin |
| CXCR7 |
chemokine (C-X-C motif) receptor 7 |
| Unidentified 4 |
Transcribed locus, moderately similar to XP_517655.1 PREDICTED: similar to KIAA0825 protein [Pan troglodytes] |
| COL5A1 |
collagen, type V, alpha 1 |
| MOBKL2B |
MOB1, Mps One Binder kinase activator-like 2B (yeast) |
| TAGLN |
transgelin |
| SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
Seo et al. Molecular Cancer 2007 6:75 doi:10.1186/1476-4598-6-75 |
|